{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:49:13Z","timestamp":1793033353131,"version":"4.5.0"},"reference-count":618,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pharmthera.2023.108383","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:28:32Z","timestamp":1678969712000},"page":"108383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies"],"prefix":"10.1016","volume":"244","author":[{"given":"Mikkel Bo","family":"Brent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jcb.240550304","article-title":"Function of osteocytes in bone","volume":"55","author":"Aarden","year":"1994","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00418-016-1414-y","article-title":"Early reversal cells in adult human bone remodeling: Osteoblastic nature, catabolic functions and interactions with osteoclasts","volume":"145","author":"Abdelgawad","year":"2016","journal-title":"Histochemistry and Cell Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1359\/jbmr.1999.14.8.1320","article-title":"Modulation of osteoblast-like cell behavior by activation of protease-activated receptor-1","volume":"14","author":"Abraham","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bone.2015.09.010","article-title":"Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia","volume":"81","author":"Achiou","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X19876468","article-title":"Glucocorticoid-induced osteoporosis: From clinical trials to clinical practice","volume":"11","author":"Adami","year":"2019","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0030","first-page":"2314","article-title":"Changes in bone mineral density and calcium metabolism in breastfeeding women: A one year follow-up study","volume":"81","author":"Affinito","year":"1996","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0035","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.mayocp.2019.03.018","article-title":"Andreas Vesalius and De Fabrica","volume":"94","author":"Afshar","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/8756-3282(92)90356-2","article-title":"Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats","volume":"13","author":"Akamine","year":"1992","journal-title":"Bone"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108383_bb0045","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jama.1934.02750160010003","article-title":"Hyperparathyroidism: A common and polymorphic condition as illustrated by seventeen proved cases from one clinic","volume":"102","author":"Albright","year":"1934","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcn\/54.1.69","article-title":"Studies in human lactation: Milk composition and daily secretion rates of macronutrients in the first year of lactation","volume":"54","author":"Allen","year":"1991","journal-title":"American Journal of Clinical Nutrition"},{"issue":"37","key":"10.1016\/j.pharmthera.2023.108383_bb0055","doi-asserted-by":"crossref","first-page":"27285","DOI":"10.1074\/jbc.M702810200","article-title":"Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids","volume":"282","author":"Almeida","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13247","article-title":"Increased marrow adipogenesis does not contribute to age-dependent appendicular bone loss in female mice","volume":"19","author":"Almeida","year":"2020","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0065","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-015-3455-9","article-title":"Fracture risk in oral glucocorticoid users: A Bayesian meta-regression leveraging control arms of osteoporosis clinical trials","volume":"27","author":"Amiche","year":"2016","journal-title":"Osteoporosis International"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajpath.2013.03.006","article-title":"Understanding coupling between bone resorption and formation: Are reversal cells the missing link?","volume":"183","author":"Andersen","year":"2013","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1083\/jcb.41.1.59","article-title":"Vesicles associated with calcification in the matrix of epiphyseal cartilage","volume":"41","author":"Anderson","year":"1969","journal-title":"The Journal of Cell Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11926-003-0071-z","article-title":"Matrix vesicles and calcification","volume":"5","author":"Anderson","year":"2003","journal-title":"Current Rheumatology Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0085","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/bj2840649","article-title":"Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes","volume":"284","author":"Anderson","year":"1992","journal-title":"Biochemical Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/0192623311416259","article-title":"Induction of heart valve lesions by small-molecule ALK5 inhibitors","volume":"39","author":"Anderton","year":"2011","journal-title":"Toxicologic Pathology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb0095","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jbmr.5650100710","article-title":"Growth hormone stimulates bone formation and strength of cortical bone in aged rats","volume":"10","author":"Andreassen","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ajcn\/67.4.685","article-title":"Bone changes after 3 mo of lactation: Influence of calcium intake, breast-milk output, and vitamin d-receptor genotype","volume":"67","author":"Ann Laskey","year":"1998","journal-title":"American Journal of Clinical Nutrition"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb0105","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1210\/en.2010-0566","article-title":"Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton","volume":"151","author":"Ardeshirpour","year":"2010","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0110","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1210\/en.2006-1467","article-title":"Weaning triggers a decrease in receptor activator of nuclear factor-\u03baB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice","volume":"148","author":"Ardeshirpour","year":"2007","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bone.2005.11.009","article-title":"The calcium-sensing receptor regulates PTHrP production and calcium transport in the lactating mammary gland","volume":"38","author":"Ardeshirpour","year":"2006","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0120","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1210\/en.2015-1232","article-title":"OPG treatment prevents bone loss during lactation but does not affect milk production or maternal calcium metabolism","volume":"156","author":"Ardeshirpour","year":"2015","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1479-5876-9-115","article-title":"Combination therapy: The next opportunity and challenge of medicine","volume":"9","author":"Ascierto","year":"2011","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/00365513.2011.624631","article-title":"Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans","volume":"72","author":"Aslan","year":"2012","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000145948","article-title":"Modification of bone formation rate by growth hormone, melanocyte-stimulating hormone, and cortisone in the normal rat","volume":"121","author":"Aspenberg","year":"1985","journal-title":"Acta Anatomica"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ajh.23732","article-title":"A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers","volume":"89","author":"Attie","year":"2014","journal-title":"American Journal of Hematology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/2230-8210.84852","article-title":"History of growth hormone therapy","volume":"15","author":"Ayyar","year":"2011","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/8756-3282(94)00035-X","article-title":"Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models","volume":"16","author":"Azuma","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2016.07.005","article-title":"Immobilization and long-term recovery results in large changes in bone structure and strength but no corresponding alterations of osteocyte lacunar properties","volume":"91","author":"Bach-Gansmo","year":"2016","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0165","first-page":"76","article-title":"Comparative bone anatomy of commonly used laboratory animals: Implications for drug discovery","volume":"61","author":"Bagi","year":"2011","journal-title":"Comparative Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ar.1092390303","article-title":"Comparison of osteopenic changes in cancellous bone induced by ovariectomy and\/or immobilization in adult rats","volume":"239","author":"Bagi","year":"1994","journal-title":"The Anatomical Record"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb0175","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jbmr.5650051011","article-title":"Metabolic modulation of disuse osteopenia: Endocrine-dependent site specificity of bone remodeling","volume":"5","author":"Bain","year":"1990","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/17453674.2010.483986","article-title":"Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid","volume":"81","author":"Baofeng","year":"2010","journal-title":"Acta Orthopaedica"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2023.108383_bb0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000516240","article-title":"Animal models in pharmacology: A brief history awarding the nobel prizes for physiology or medicine","volume":"106","author":"Baptista","year":"2021","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-017-1440-0","article-title":"Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: A systematic review and meta-analysis","volume":"59","author":"Barake","year":"2018","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0205","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1210\/endo-128-3-1459","article-title":"Growth hormone (Gh) receptors in clonal osteoblast- like cells mediate a mitogenic response to gh","volume":"128","author":"Barnardt","year":"1991","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: From human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0215","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.63","article-title":"Animal models are essential to biological research: Issues and perspectives","volume":"1","author":"Barr\u00e9-Sinoussi","year":"2015","journal-title":"Future Science OA"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0220","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1152\/japplphysiol.01167.2004","article-title":"Physiological aspects of high-altitude pulmonary edema","volume":"98","author":"B\u00e4rtsch","year":"2005","journal-title":"Journal of Applied Physiology"},{"issue":"9373","key":"10.1016\/j.pharmthera.2023.108383_bb0225","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(03)13591-X","article-title":"High-altitude illness","volume":"361","author":"Basnyat","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/ham.2012.1042","article-title":"Determination of bone mass using multisite quantitative ultrasound and biochemical markers of bone turnover during residency at extreme altitude: A longitudinal study","volume":"14","author":"Basu","year":"2013","journal-title":"High Altitude Medicine and Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/ham.2013.1098","article-title":"Alterations in different indices of skeletal health after prolonged residency at high altitude","volume":"15","author":"Basu","year":"2014","journal-title":"High Altitude Medicine and Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0240","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.bbamem.2011.09.018","article-title":"Gap junctions and hemichannels in signal transmission, function and development of bone","volume":"1818","author":"Batra","year":"2012","journal-title":"Biochimica et Biophysica Acta - Biomembranes"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0245","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1152\/ajplegacy.1971.221.3.669","article-title":"Bone formation by osteocytes","volume":"221","author":"Baylink","year":"1971","journal-title":"The American Journal of Physiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0250","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone","volume":"16","author":"Beavan","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02279101","article-title":"Osteocytic osteolysis","volume":"4","author":"B\u00e9langer","year":"1969","journal-title":"Calcified Tissue Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0260","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1210\/endo-121-6-1985","article-title":"Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro","volume":"121","author":"Bellows","year":"1987","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40610-015-0018-y","article-title":"Adipose tissue-residing progenitors (adipocyte lineage progenitors and adipose-derived stem cells (ADSC))","volume":"1","author":"Berry","year":"2015","journal-title":"Current Molecular Biology Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cpdd.386","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of domagrozumab (PF-06252616), an antimyostatin monoclonal antibody, in healthy subjects","volume":"7","author":"Bhattacharya","year":"2018","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcp.2019.05.024","article-title":"Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide","volume":"166","author":"Bhattacharyya","year":"2019","journal-title":"Biochemical Pharmacology"},{"issue":"9041","key":"10.1016\/j.pharmthera.2023.108383_bb0280","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108383_bb0285","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108383_bb0290","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0295","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb0300","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00007611-198910000-00013","article-title":"Francois Magendie, Claude Bernard, and the interrelation of science, history, and philosophy","volume":"82","author":"Bloch","year":"1989","journal-title":"Southern Medical Journal"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-59745-104-8_9","article-title":"Orchidectomy models of osteoporosis","volume":"455","author":"Blouin","year":"2008","journal-title":"Methods in Molecular Biology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb0310","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0315","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb0320","first-page":"3516","article-title":"FGF-21 and skeletal remodeling during and after lactation in C57BL\/6J mice","volume":"155","author":"Bornstein","year":"2014","journal-title":"Endocrinology (United States)"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2013.181","article-title":"Bone composition: Relationship to bone fragility and antiosteoporotic drug effects","volume":"2","author":"Boskey","year":"2013","journal-title":"BoneKEy Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0330","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/JOE-20-0428","article-title":"Regulation of mineralisation in bone and vascular tissue: A comparative review","volume":"248","author":"Bourne","year":"2021","journal-title":"Journal of Endocrinology"},{"issue":"6937","key":"10.1016\/j.pharmthera.2023.108383_bb0335","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0340","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/ham.2013.1038","article-title":"Static biomechanics in bone from growing rats exposed chronically to simulated high altitudes","volume":"14","author":"Bozzini","year":"2013","journal-title":"High Altitude Medicine and Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0345","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.aanat.2008.11.002","article-title":"Long-term exposure to hypobaric hypoxia in rat affects femur cross-sectional geometry and bone tissue material properties","volume":"191","author":"Bozzini","year":"2009","journal-title":"Annals of Anatomy"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0350","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/ham.2015.0105","article-title":"Structural and material mechanical quality of femoral shafts in rats exposed to simulated high altitude from infancy to adulthood","volume":"17","author":"Bozzini","year":"2016","journal-title":"High Altitude Medicine and Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0355","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.physbeh.2009.04.025","article-title":"Estrogen regulation of apoptosis in osteoblasts","volume":"99","author":"Bradford","year":"2010","journal-title":"Physiology and Behavior"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0360","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.4223","article-title":"Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells","volume":"280","author":"Br\u00e4ndstr\u00f6m","year":"2001","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0365","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archopht.1954.00920050335001","article-title":"Carbonic anhydrase inhibitor acetazoleamide (DIAMOX): A new approach to the therapy of glaucoma. A.M.A","volume":"52","author":"Breinin","year":"1954","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0370","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/jc.2014-2825","article-title":"Changes in cortical volumetric bone mineral density and thickness, and trabecular thickness in lactating women postpartum","volume":"100","author":"Brembeck","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174409","article-title":"Abaloparatide: A review of preclinical and clinical studies","volume":"909","author":"Brent","year":"2021","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116258","article-title":"A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone loss","volume":"154","author":"Brent","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0385","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2018.02.017","article-title":"PTH (1\u201334) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats","volume":"110","author":"Brent","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13643-020-01441-3","article-title":"Animal models of disuse-induced bone loss: Study protocol for a systematic review","volume":"9","author":"Brent","year":"2020","journal-title":"Systematic Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0395","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00223-020-00799-9","article-title":"A systematic review of animal models of disuse-induced Bone loss","volume":"108","author":"Brent","year":"2021","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100114","article-title":"Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice","volume":"5","author":"Brent","year":"2021","journal-title":"Endocrine and Metabolic Science"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116417","article-title":"Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats","volume":"160","author":"Brent","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116203","article-title":"Hypobaric hypoxia deteriorates bone mass and strength in mice","volume":"154","author":"Brent","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115692","article-title":"Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice","volume":"142","author":"Brent","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.101079","article-title":"Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A","volume":"7","author":"Brent","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.831369","article-title":"Effect of acetazolamide and zoledronate on simulated high altitude-induced Bone loss","volume":"13","author":"Brent","year":"2022","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0430","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fendo.2021.628994","article-title":"Teriparatide and Abaloparatide have a similar effect on bone in mice","volume":"12","author":"Brent","year":"2021","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0435","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bonr.2017.12.001","article-title":"The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice","volume":"8","author":"Brent","year":"2018","journal-title":"Bone Reports"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0440","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fendo.2020.588773","article-title":"The efficacy of PTH and abaloparatide to counteract immobilization-induced osteopenia is in general similar","volume":"11","author":"Brent","year":"2020","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0445","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1038\/s41598-021-91729-8","article-title":"Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice","volume":"11","author":"Brent","year":"2021","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb0450","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1359\/jbmr.1998.13.11.1721","article-title":"Human osteoclast formation and activity in vitro: Effects of alendronate","volume":"13","author":"Breuil","year":"1998","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0455","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000014","article-title":"Glucocorticoid-induced osteoporosis","volume":"1","author":"Briot","year":"2015","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0460","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/ham.2020.0164","article-title":"The effect of normobaric intermittent hypoxia therapy on bone in normal and disuse osteopenic mice","volume":"22","author":"Bromer","year":"2021","journal-title":"High Altitude Medicine and Biology"},{"issue":"6185","key":"10.1016\/j.pharmthera.2023.108383_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/science.1249783","article-title":"Mechanism of activation of protein kinase JAK2 by the growth hormone receptor","volume":"344","author":"Brooks","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0470","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2012.11.037","article-title":"PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats","volume":"53","author":"Br\u00fcel","year":"2013","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0475","first-page":"207","article-title":"The mighty mouse: The impact of rodents on advances in biomedical research","volume":"110","author":"Bryda","year":"2013","journal-title":"Missouri Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2015.08.001","article-title":"The history of cortisone discovery and development","volume":"42","author":"Burns","year":"2016","journal-title":"Rheumatic Disease Clinics of North America"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/107632700300003323","article-title":"Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells","volume":"7","author":"Buttery","year":"2001","journal-title":"Tissue Engineering"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0490","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: Current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0495","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/14756366.2015.1051042","article-title":"The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Pu\u015fca\u015f (1932-2015)","volume":"31","author":"Buz\u00e1s","year":"2016","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0500","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1152\/ajplegacy.1962.202.3.429","article-title":"Effects of acetazolamide and metabolic acidosis and alkalosis upon gastric acid secretion","volume":"202","author":"Byers","year":"1962","journal-title":"The American Journal of Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb0505","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/jbmr.2807","article-title":"Osteocyte apoptosis caused by hindlimb unloading is required to trigger osteocyte RANKL production and subsequent resorption of cortical and trabecular bone in mice femurs","volume":"31","author":"Cabahug-Zuckerman","year":"2016","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0510","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2265.1994.tb02788.x","article-title":"Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women","volume":"41","author":"Caird","year":"1994","journal-title":"Clinical Endocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb0515","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1016\/S0021-9258(18)42663-4","article-title":"Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts","volume":"267","author":"Campbell","year":"1992","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb0520","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: Pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporosis International"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0525","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/bloodadvances.2020002725","article-title":"The use of luspatercept for thalassemia in adults","volume":"5","author":"Cappellini","year":"2021","journal-title":"Blood Advances"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108383_bb0530","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0535","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jc.2012-2118","article-title":"Evaluation of markers of bone turnover during lactation in African-Americans: A comparison with caucasian lactation","volume":"98","author":"Carneiro","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0540","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/jc.2009-1518","article-title":"Lactation and bone turnover: A conundrum of marked bone loss in the setting of coupled bone turnover","volume":"95","author":"Carneiro","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb0545","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s004670000366","article-title":"Role of the tyrosine kinase JAK2 in signal transduction by growth hormone","volume":"14","author":"Carter-Su","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0550","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/jpet.118.252304","article-title":"Follistatin-288-Fc fusion protein promotes localized growth of skeletal muscle","volume":"368","author":"Castonguay","year":"2019","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0555","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/en.2015-1477","article-title":"Expansion of bone marrow adipose tissue during caloric restriction is associated with increased circulating glucocorticoids and not with hypoleptinemia","volume":"157","author":"Cawthorn","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0560","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ajcn\/36.3.438","article-title":"Growth and bone mineralization of normal breast-fed infants and the effects of lactation on maternal bone mineral status","volume":"36","author":"Chan","year":"1982","journal-title":"American Journal of Clinical Nutrition"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb0565","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.ejcn.1602148","article-title":"Bone mineral density and calcium metabolism of Hong Kong Chinese postpartum women - A 1-y longitudinal study","volume":"59","author":"Chan","year":"2005","journal-title":"European Journal of Clinical Nutrition"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0570","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-019-04999-4","article-title":"Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia","volume":"30","author":"Chandler","year":"2019","journal-title":"Osteoporosis International"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2023.108383_bb0575","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tox.2009.01.016","article-title":"Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts","volume":"258","author":"Chang","year":"2009","journal-title":"Toxicology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb0580","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrendo.2015.139","article-title":"PTH receptor-1 signalling - mechanistic insights and therapeutic prospects","volume":"11","author":"Cheloha","year":"2015","journal-title":"Nature Reviews Endocrinology"},{"issue":"26","key":"10.1016\/j.pharmthera.2023.108383_bb0585","first-page":"E5266","article-title":"Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108383_bb0590","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V128.22.2463.2463","article-title":"Pharmacokinetics and exposure-response of luspatercept in patients with beta-thalassemia: Preliminary results from phase 2 studies","volume":"128","author":"Chen","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0595","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/endo.134.1.8275945","article-title":"Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone","volume":"134","author":"Cheng","year":"1994","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0600","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0605","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0899-9007(99)00055-6","article-title":"Postpartum body composition changes in lactating and non-lactating primiparas","volume":"15","author":"Chou","year":"1999","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0610","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI115588","article-title":"Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation","volume":"89","author":"Chow","year":"1992","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10375","article-title":"Administration of denosumab preserves bone mineral density at the knee in persons with subacute spinal cord injury: Findings from a randomized clinical trial","volume":"4","author":"Cirnigliaro","year":"2020","journal-title":"JBMR Plus"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2023.108383_bb0620","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clinical Journal of the American Society of Nephrology\u00a0: CJASN"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0625","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.rcl.2010.02.014","article-title":"Physiology of bone loss","volume":"48","author":"Clarke","year":"2010","journal-title":"Radiologic Clinics of North America"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0630","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/keaa755","article-title":"Osteosarcopenia: Where osteoporosis and sarcopenia collide","volume":"60","author":"Clynes","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-01360-w","article-title":"Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation","volume":"11","author":"Cohen","year":"2021","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0640","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1210\/en.2012-1931","article-title":"Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes","volume":"154","author":"Collins","year":"2013","journal-title":"Endocrinology"},{"issue":"10169","key":"10.1016\/j.pharmthera.2023.108383_bb0645","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"The Lancet"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108383_bb0650","first-page":"1659","article-title":"A review of osteocyte function and the emerging importance of sclerostin","volume":"96","author":"Compton","year":"2014","journal-title":"Journal of Bone and Joint Surgery (American)"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0655","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2016.08.024","article-title":"Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity","volume":"93","author":"Conaway","year":"2016","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0660","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02547231","article-title":"Immobilization and bone mass in rats - Effects of parathyroidectomy and acetazolamide","volume":"11","author":"Conaway","year":"1973","journal-title":"Calcified Tissue Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0665","article-title":"Novel mechanisms targeted by drug trials in pulmonary arterial hypertension","author":"Condon","year":"2021","journal-title":"Chest, 161(4), 1060\u20131072"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0670","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00128-012-0602-2","article-title":"Effects of lead exposure on growth and bone biology in growing rats exposed to simulated high altitude","volume":"88","author":"Conti","year":"2012","journal-title":"Bulletin of Environmental Contamination and Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-019-0601-6","article-title":"Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos)","volume":"14","author":"Cooke-Hubley","year":"2019","journal-title":"Archives of Osteoporosis"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108383_bb0680","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0685","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.coph.2006.03.005","article-title":"Recent advances in understanding the mechanism of action of bisphosphonates","volume":"6","author":"Coxon","year":"2006","journal-title":"Current Opinion in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0690","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/AOG.0000000000002096","article-title":"Associations of parity, breastfeeding, and fractures in the women\u2019s health observational study","volume":"130","author":"Crandall","year":"2017","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0695","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb0700","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jbmr.5650100907","article-title":"Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium","volume":"10","author":"Cross","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0710","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bone.2016.04.007","article-title":"Characterisation of matrix vesicles in skeletal and soft tissue mineralisation","volume":"87","author":"Cui","year":"2016","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2023.108383_bb0715","first-page":"M460","article-title":"BIM-44058, a novel analog of PTHrP with enhanced Bone building activity, but decreased calcium-mobilization potential","volume":"16","author":"Culler","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108383_bb0720","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"Journal of the American Medical Association"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0725","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/art.21194","article-title":"Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients","volume":"52","author":"Curtis","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0730","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bulletin of The John Hopkins Hospital"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0735","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fcell.2020.00433","article-title":"Cathepsin K: The action in and beyond bone","volume":"8","author":"Dai","year":"2020","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0740","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: An endocrine cell \u2026 and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0745","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","article-title":"Fracture risk with intermittent high-dose oral glucocorticoid therapy","volume":"56","author":"De Vries","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"FEB","key":"10.1016\/j.pharmthera.2023.108383_bb0750","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: Mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0755","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2014.56","article-title":"The reversal phase of the bone-remodeling cycle: Cellular prerequisites for coupling resorption and formation","volume":"3","author":"Delaisse","year":"2014","journal-title":"BoneKEy Reports"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0760","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0765","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1759720X11430858","article-title":"Aging and bone loss: New insights for the clinician","volume":"4","author":"Demontiero","year":"2012","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0770","first-page":"47","article-title":"Multiple effects of growth hormone in the body: Is it really the hormone for growth?","volume":"9","author":"Devesa","year":"2016","journal-title":"Clinical Medicine Insights: Endocrinology and Diabetes"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb0775","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jbmr.82","article-title":"Caloric restriction leads to high marrow adiposity and low bone mass in growing mice","volume":"25","author":"Devlin","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0780","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mam.2008.01.001","article-title":"Thrombin","volume":"29","author":"Di Cera","year":"2008","journal-title":"Molecular Aspects of Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0785","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0790","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0169-6009(91)90092-E","article-title":"Bone density changes during pregnancy and lactation in active women: A longitudinal study","volume":"14","author":"Drinkwater","year":"1991","journal-title":"Bone and Mineral"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0795","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.exger.2008.10.004","article-title":"Age-related bone loss in the LOU\/c rat model of healthy ageing","volume":"44","author":"Duque","year":"2009","journal-title":"Experimental Gerontology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0800","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00271086","article-title":"Periosteocyte demineralization in disuse osteoporosis","volume":"5","author":"Duriez","year":"1982","journal-title":"International Orthopaedics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nature Reviews. Disease Primers"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0810","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/endo.142.3.8048","article-title":"Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits","volume":"142","author":"Eberhardt","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0815","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2015.04.016","article-title":"Osteoporosis and sarcopenia in older age","volume":"80","author":"Edwards","year":"2015","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0820","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0825","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1067\/mem.2002.126373","article-title":"Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis [2]","volume":"40","author":"Elinav","year":"2002","journal-title":"Annals of Emergency Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0830","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/EJE-11-1050","article-title":"PTHrP-associated hypercalcemia of pregnancy resolved after delivery: A case report","volume":"166","author":"Eller-Vainicher","year":"2012","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0835","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1079\/BJN19520027","article-title":"Skeletal changes during pregnancy and lactation in the rat: Effect of different levels of dietary calcium","volume":"6","author":"Ellinger","year":"1952","journal-title":"British Journal of Nutrition"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0840","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000327788","article-title":"Mechanisms of growth plate maturation and epiphyseal fusion","volume":"75","author":"Emons","year":"2011","journal-title":"Hormone Research in P\u00e6diatrics"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb0845","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archopht.1977.04450080088009","article-title":"Carbonic anhydrase inhibitor side effects: Serum chemical analysis","volume":"95","author":"Epstein","year":"1977","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0850","first-page":"201","article-title":"A brief history of animal modeling","volume":"110","author":"Ericsson","year":"2013","journal-title":"Missouri Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0855","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/edrv-7-4-379","article-title":"Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease","volume":"7","author":"Eriksen","year":"1986","journal-title":"Endocrine Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb0860","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0221-8747(84)90066-3","article-title":"Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition","volume":"5","author":"Eriksen","year":"1984","journal-title":"Metabolic Bone Disease & Related Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0865","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcp.21335","article-title":"Regulation of Bim in glucocorticoid-mediated osteoblast apoptosis","volume":"215","author":"Espina","year":"2008","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0870","series-title":"Evaluation of new medicinal products in the treatment of primary osteoporosis","author":"European Medicines Agency","year":"2007"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0875","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1359\/jbmr.2002.17.1.77","article-title":"The bone lining cell: Its role in cleaning Howship\u2019s lacunae and initiating bone formation","volume":"17","author":"Everts","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9113439","article-title":"Anti-sclerostin antibodies in osteoporosis and other bone diseases","volume":"9","author":"Fabre","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0885","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","article-title":"Parathyroid hormone directs bone marrow mesenchymal cell fate","volume":"25","author":"Fan","year":"2017","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0890","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0169-6009(89)90081-0","article-title":"Antiestrogen and antiandrogen administration reduce bone mass in the rat","volume":"7","author":"Feldmann","year":"1989","journal-title":"Bone and Mineral"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb0895","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1007\/s00198-005-2016-z","article-title":"Practice patterns in patients at risk for glucocorticoid-induced osteoporosis","volume":"16","author":"Feldstein","year":"2005","journal-title":"Osteoporosis International"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb0900","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1908892","article-title":"Luspatercept in patients with lower-risk myelodysplastic syndromes","volume":"382","author":"Fenaux","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0905","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/endo-101-4-1310","article-title":"Hormone production by the pituitary and testes of male C57BL\/6J mice during aging","volume":"101","author":"Finch","year":"1977","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0910","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0169-6009(89)90021-4","article-title":"Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone","volume":"6","author":"Flanagan","year":"1989","journal-title":"Bone and Mineral"},{"issue":"3899","key":"10.1016\/j.pharmthera.2023.108383_bb0915","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch","year":"1969","journal-title":"Science"},{"issue":"5202","key":"10.1016\/j.pharmthera.2023.108383_bb0920","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/223211a0","article-title":"Prevention by a diphosphonate of immobilization \u201costeoporosis\u201d in rats","volume":"223","author":"Fleisch","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0925","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: Structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"BioMed Research International"},{"issue":"August","key":"10.1016\/j.pharmthera.2023.108383_bb0930","article-title":"Osteoporosis: Nonclinical evaluation of drugs intended for treatment","author":"Food and Drug Administration","year":"2019","journal-title":"Guidance for Industry"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108383_bb0935","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJM196810172791601","article-title":"Effect of acetazolamide on acute mountain sickness","volume":"279","author":"Forwand","year":"1968","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0940","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00223-006-0108-1","article-title":"Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength","volume":"79","author":"Fox","year":"2006","journal-title":"Calcified Tissue International"},{"issue":"3899","key":"10.1016\/j.pharmthera.2023.108383_bb0945","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","article-title":"Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo","volume":"165","author":"Francis","year":"1969","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0950","first-page":"2","article-title":"Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases","volume":"7","author":"Francis","year":"2007","journal-title":"Journal of Musculoskeletal & Neuronal Interactions"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0955","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/dvdy.20603","article-title":"Buried alive: How osteoblasts become osteocytes","volume":"235","author":"Franz-Odendaal","year":"2006","journal-title":"Developmental Dynamics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0960","first-page":"339","article-title":"Scanning electron microscopy studies of collagen, mineral and ground substance in human cortical bone","volume":"1981","author":"Frasca","year":"1981","journal-title":"Scanning Electron Microscopy"},{"key":"10.1016\/j.pharmthera.2023.108383_bb0965","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00003086-198305000-00047","article-title":"A determinant of bone architecture. The minimum effective strain","volume":"175","author":"Frost","year":"1983","journal-title":"Clinical Orthopaedics and Related Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0970","first-page":"175","article-title":"Wolff\u2019s law and bone\u2019s structural adaptations to mechanical usage: An overview for clinicians","volume":"64","author":"Frost","year":"1994","journal-title":"Angle Orthodontist"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb0975","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s007740070001","article-title":"The Utah paradigm of skeletal physiology: An overview of its insights for bone, cartilage and collagenous tissue organs","volume":"18","author":"Frost","year":"2000","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0980","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0038-1632695","article-title":"The Utah paradigm of skeletal physiology: What is it?","volume":"14","author":"Frost","year":"2001","journal-title":"Veterinary and Comparative Orthopaedics and Traumatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb0985","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1210\/jc.2013-3249","article-title":"Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women","volume":"99","author":"Fujita","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb0990","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1292\/jvms.55.565","article-title":"Histomorphometric changes in iliac trabecular bone during pregnancy and lactation in beagle dogs","volume":"55","author":"Fukuda","year":"1993","journal-title":"Journal of Veterinary Medical Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb0995","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","author":"Fumoto","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133847","article-title":"Differential effects of dabigatran and warfarin on bone volume and structure in rats with normal renal function","volume":"10","author":"Fusaro","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dom.13042","article-title":"Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals","volume":"20","author":"Garito","year":"2018","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jbmr.5650050111","article-title":"Parathyroid hormone is not required for normal milk composition or secretion or lactation-associated bone loss in normocalcemic rats","volume":"5","author":"Garner","year":"1990","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-hydroxysteroid dehydrogenase 1: Translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocrine Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1025","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","article-title":"Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss","volume":"95","author":"Gaudio","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1030","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.1996.270.5.C1478","article-title":"Growth hormone regulates cytosolic free calcium in rat fat cells by maintaining L-type calcium channels","volume":"270","author":"Gaur","year":"1996","journal-title":"American Journal of Physiology - Cell Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jcb.22559","article-title":"Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts","volume":"110","author":"Genetos","year":"2010","journal-title":"Journal of Cellular Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11914-019-00520-2","article-title":"Integrins in osteocyte biology and mechanotransduction","volume":"17","author":"Geoghegan","year":"2019","journal-title":"Current Osteoporosis Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1045","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41598-017-03014-2","article-title":"One-month spaceflight compromises the bone microstructure, tissue-level mechanical properties, osteocyte survival and lacunae volume in mature mice skeletons","volume":"7","author":"Gerbaix","year":"2017","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10790268.2006.11753898","article-title":"Bone loss and muscle atrophy in spinal cord injury: Epidemiology, fracture prediction, and rehabilitation strategies","volume":"29","author":"Giangregorio","year":"2006","journal-title":"The Journal of Spinal Cord Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.3217","article-title":"Absence of calcitriol causes increased lactational bone loss and lower milk calcium but does not impair post-lactation bone recovery in Cyp27b1 null mice","volume":"33","author":"Gillies","year":"2018","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcb.20777","article-title":"Playing with bone and fat","volume":"98","author":"Gimble","year":"2006","journal-title":"Journal of Cellular Biochemistry"},{"issue":"33","key":"10.1016\/j.pharmthera.2023.108383_bb1065","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1074\/jbc.M117.782128","article-title":"Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass","volume":"292","author":"Goh","year":"2017","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00774-017-0854-3","article-title":"Inhaled glucocorticoids are associated with vertebral fractures in COPD patients","volume":"36","author":"Gon\u00e7alves","year":"2018","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1075","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.bone.2009.01.008","article-title":"A comparison of cortical and trabecular bone from C57 Black 6 mice using Raman spectroscopy","volume":"44","author":"Goodyear","year":"2009","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1080","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cyto.2011.09.005","article-title":"Primary human bone marrow adipocytes support TNF-\u03b1-induced osteoclast differentiation and function through RANKL expression","volume":"56","author":"Goto","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2009-01-197988","article-title":"Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with \u03b19\u03b21and \u03b14\u03b21 integrins","volume":"114","author":"Grassinger","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1759720X16650866","article-title":"Intravenous zoledronate for osteoporosis: Less might be more","volume":"8","author":"Grey","year":"2016","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ng0997-71","article-title":"A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle","volume":"17","author":"Grobet","year":"1997","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1100","first-page":"473","article-title":"Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats","volume":"14","author":"Grubbe","year":"2014","journal-title":"Journal of Musculoskeletal & Neuronal Interactions"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1105","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2013.171","article-title":"IGF-1 regulation of key signaling pathways in bone","volume":"2","author":"Guntur","year":"2013","journal-title":"BoneKEy Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM200107123450206","article-title":"High-altitude illness","volume":"345","author":"Hackett","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/1527029041352054","article-title":"High altitude cerebral edema","volume":"5","author":"Hackett","year":"2004","journal-title":"High Altitude Medicine and Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jbmr.5650050205","article-title":"A scanning electron microscopic and photon absorptiometric study of the development, prolongation, and pattern of recovery from lactation-induced osteopenia in Rats","volume":"5","author":"Hagaman","year":"1990","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/1995-705X.81548","article-title":"Animal testing and medicine","volume":"12","author":"Hajar","year":"2011","journal-title":"Heart Views"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1130","doi-asserted-by":"crossref","DOI":"10.1007\/BF02556255","article-title":"A comparison of the effects of inhibitors of carbonic anhydrase on osteoclastic bone resorption and purified carbonic anhydrase isozyme II","volume":"49","author":"Hall","year":"1991","journal-title":"Calcified Tissue International"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb1135","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jbmr.5650100805","article-title":"Skeletal unloading induces selective resistance to the anabolic actions of growth hormone on bone","volume":"10","author":"Halloran","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1140","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/endo-107-6-1923","article-title":"Skeletal changes during pregnancy and lactation: The role of vitamin D","volume":"107","author":"Halloran","year":"1980","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1498-0","article-title":"The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor","volume":"10","author":"Han","year":"2019","journal-title":"Stem Cell Research & Therapy"},{"issue":"AUG","key":"10.1016\/j.pharmthera.2023.108383_bb1150","article-title":"Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells?","volume":"2","author":"Hardy","year":"2010","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-020-0371-y","article-title":"Therapeutic glucocorticoids: Mechanisms of actions in rheumatic diseases","volume":"16","author":"Hardy","year":"2020","journal-title":"Nature Reviews Rheumatology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: Consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocrine Reviews"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108383_bb1165","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1170","first-page":"114","article-title":"Mechanical basis of bone strength: Influence of bone material, bone structure and muscle action","volume":"17","author":"Hart","year":"2017","journal-title":"Journal of Musculoskeletal & Neuronal Interactions"},{"issue":"SUPPL.2","key":"10.1016\/j.pharmthera.2023.108383_bb1175","article-title":"Thoughts on limitations of animal models","volume":"14","author":"Hartung","year":"2008","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41968","article-title":"Piezo\u2019s membrane footprint and its contribution to mechanosensitivity","volume":"7","author":"Haselwandter","year":"2018","journal-title":"ELife"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/ajcn\/58.2.152","article-title":"Energy and protein intakes of breast-fed and formula-fed infants during the first year of life and their association with growth velocity: The darling study","volume":"58","author":"Heinig","year":"1993","journal-title":"American Journal of Clinical Nutrition"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1195","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/archinte.1985.00360100075012","article-title":"Significant metabolic acidosis induced by acetazolamide: Not a rare complication","volume":"145","author":"Heller","year":"1985","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1200","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1067\/mob.2000.107468","article-title":"Bone mineral density in grand multiparous women with extended lactation","volume":"182","author":"Henderson","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2011.06.013","article-title":"Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism","volume":"49","author":"Henneicke","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ani3010238","article-title":"Animal experiments in biomedical research: A historical perspective","volume":"3","author":"Henrique Franco","year":"2013","journal-title":"Animals"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1215","first-page":"4479","article-title":"Clinical development of galunisertib (Ly2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug Design, Development and Therapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1220","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1530\/EC-14-0070","article-title":"Heroes in endocrinology: nobel prizes","volume":"3","author":"de Herder","year":"2014","journal-title":"Endocrine Connections"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1225","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bone.2004.07.002","article-title":"Osteocyte density in woven bone","volume":"35","author":"Hernandez","year":"2004","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.steroids.2008.11.009","article-title":"The challenge of continuous exogenous glucocorticoid administration in mice","volume":"74","author":"Herrmann","year":"2009","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1235","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocrine Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1240","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1245","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1530\/JME-18-0176","article-title":"Novel actions of sclerostin on bone","volume":"62","author":"Holdsworth","year":"2019","journal-title":"Journal of Molecular Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1250","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/jn\/130.4.777","article-title":"Lactation delays postpartum bone mineral accretion and temporarily alters its regional distribution in women","volume":"130","author":"Hopkinson","year":"2000","journal-title":"The Journal of Nutrition"},{"issue":"5108","key":"10.1016\/j.pharmthera.2023.108383_bb1255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.8480174","article-title":"Cytokines and estrogen in bone: Anti-osteoporotic effects","volume":"260","author":"Horowitz","year":"1993","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/21623945.2017.1367881","article-title":"Bone marrow adipocytes","volume":"6","author":"Horowitz","year":"2017","journal-title":"Adipocyte"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020360","article-title":"Mesenchymal stem cells: Cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment","volume":"19","author":"Hu","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-2-9","article-title":"Regulation of TGF-\u03b2 receptor activity","volume":"2","author":"Huang","year":"2012","journal-title":"Cell & Bioscience"},{"issue":"8 August","key":"10.1016\/j.pharmthera.2023.108383_bb1275","doi-asserted-by":"crossref","first-page":"e0236919","DOI":"10.1371\/journal.pone.0236919","article-title":"Mountaineers on Mount Everest: Effects of age, sex, experience, and crowding on rates of success and death","volume":"15","author":"Huey","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4757-3401-0_15","article-title":"Mountaineering in thin air: Patterns of death and of weather at high altitude","volume":"502","author":"Huey","year":"2001","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1285","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1098\/rsbl.2007.0317","article-title":"Effects of age and gender on success and death of mountaineers on Mount Everest","volume":"3","author":"Huey","year":"2007","journal-title":"Biology Letters"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1290","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","article-title":"Age and bone mass as predictors of fracture in a prospective study","volume":"81","author":"Hui","year":"1988","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.47.1.267","article-title":"High-altitude pulmonary edema: Current concepts","volume":"47","author":"Hultgren","year":"1996","journal-title":"Annual Review of Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb1300","first-page":"2394","article-title":"Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases","volume":"9","author":"Ibrahim","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1305","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","article-title":"The multiple functions and mechanisms of osteopontin","volume":"59","author":"Icer","year":"2018","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1310","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fendo.2019.00794","article-title":"Neuromuscular diseases and bone","volume":"10","author":"Iolascon","year":"2019","journal-title":"Frontiers in Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s002239900505","article-title":"Comparison of cytotoxic effects of bisphosphonates in vitro and in vivo","volume":"63","author":"Ito","year":"1998","journal-title":"Calcified Tissue International"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-008-9146-1","article-title":"Effects of vitamin K2 and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats","volume":"83","author":"Iwamoto","year":"2008","journal-title":"Calcified Tissue International"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb1325","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1359\/jbmr.060402","article-title":"Strain-dependent variations in the response of cancellous bone to ovariectomy in mice","volume":"21","author":"Iwaniec","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1330","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I","article-title":"Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro","volume":"64","author":"Jaiswal","year":"1997","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1335","first-page":"193","article-title":"Overview: Animal models of osteopenia and osteoporosis","volume":"1","author":"Jee","year":"2001","journal-title":"Journal of Musculoskeletal & Neuronal Interactions"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2265.2005.02404.x","article-title":"Does growth hormone cause cancer?","volume":"64","author":"Jenkins","year":"2006","journal-title":"Clinical Endocrinology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb1345","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1350","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1096\/fj.11-182519","article-title":"Glucocorticoid dose determines osteocyte cell fate","volume":"25","author":"Jia","year":"2011","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1355","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2741\/2159","article-title":"Roles of gap junctions and hemichannels in bone cell functions and in signal transmission of mechanical stress","volume":"12","author":"Jiang","year":"2007","journal-title":"Frontiers in Bioscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1360","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/gerona\/glt046","article-title":"The relevance of mouse models for investigating age-related bone loss in humans","volume":"68","author":"Jilka","year":"2013","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1365","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/8756-3282(91)90022-B","article-title":"Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone","volume":"12","author":"J\u00f8rgensen","year":"1991","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1370","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10637-019-00835-y","article-title":"Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study","volume":"38","author":"Jung","year":"2020","journal-title":"Investigational New Drugs"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1375","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/en.2003-1427","article-title":"Mice deficient in 11\u03b2-hydroxysteroid denydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation","volume":"145","author":"Justesen","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1380","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/bbrc.1993.1798","article-title":"Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide","volume":"194","author":"Kaji","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1385","series-title":"Dabigatran etexilate, a new direct thrombin inhibitor, enhances bone mass, inhibits bone resorption and stimulates bone formation in mice. ASBMR 2014 Annual Meeting, S260","author":"Kalinowski","year":"2014"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb1390","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJM199708213370803","article-title":"The effect of calcium supplementation on bone density during lactation and after weaning","volume":"337","author":"Kalkwarf","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1395","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone and Mineral"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1400","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s001980170033","article-title":"Pregnancy and lactation confer reversible bone loss in humans","volume":"12","author":"Karlsson","year":"2001","journal-title":"Osteoporosis International"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00223-010-9443-3","article-title":"Localization and expression of prothrombin in rodent osteoclasts and long bones","volume":"88","author":"Karlstr\u00f6m","year":"2011","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2015.11.019","article-title":"Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis","volume":"84","author":"Karunaratne","year":"2016","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1415","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CRD.0b013e31822b4939","article-title":"Acetazolamide: A forgotten diuretic agent","volume":"19","author":"Kassamali","year":"2011","journal-title":"Cardiology in Review"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1420","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.3044","article-title":"Lactation-induced changes in the volume of osteocyte lacunar-canalicular space Alter mechanical properties in cortical Bone tissue","volume":"32","author":"Kaya","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1425","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jbmr.3876","article-title":"YAP and TAZ mediate osteocyte perilacunar\/canalicular remodeling","volume":"35","author":"Kegelman","year":"2020","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1430","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1096\/fj.201700872R","article-title":"Skeletal cell YAP and TAZ combinatorially promote bone development","volume":"32","author":"Kegelman","year":"2018","journal-title":"FASEB Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1435","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/bcp.13791","article-title":"Regulatory aspects of the development of drugs for metabolic bone diseases \u2013 FDA and EMA perspective","volume":"85","author":"Kehoe","year":"2019","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000138104","article-title":"Role of carbonic anhydrase in bone: Plasma acetazolamide concentrations associated with inhibition of bone loss","volume":"31","author":"Kenny","year":"1985","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1445","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02554831","article-title":"Role of carbonic anhydrase in bone: Partial inhibition of disuse atrophy of bone by parenteral acetazolamide","volume":"37","author":"Kenny","year":"1985","journal-title":"Calcified Tissue International"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1450","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.5650050409","article-title":"Human lactation: Forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaning","volume":"5","author":"Kent","year":"1990","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1455","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bone.2016.03.016","article-title":"Estrogen receptors alpha and beta in bone","volume":"87","author":"Khalid","year":"2016","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb1460","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2017.136","article-title":"Romosozumab - on track or derailed?","volume":"13","author":"Khosla","year":"2017","journal-title":"Nature Reviews Endocrinology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1465","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00198-008-0591-5","article-title":"Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density","volume":"19","author":"Khosla","year":"2008","journal-title":"Osteoporosis International"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb1470","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: Recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb1475","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/jcem.86.8.7736","article-title":"Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men","volume":"86","author":"Khosla","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb1480","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108383_bb1485","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM199004193221613","article-title":"Parathyroid hormone\u2013related protein and hypercalcemia secondary to massive mammary hyperplasia","volume":"322","author":"Khosla","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb1490","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1495","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002239900107","article-title":"Effects of continuous glucocorticoid infusion on bone metabolism in the rat","volume":"59","author":"King","year":"1996","journal-title":"Calcified Tissue International"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1500","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jbmr.339","article-title":"Skeletal recovery after weaning does not require PTHrP","volume":"26","author":"Kirby","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1505","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/jbmr.1925","article-title":"Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone","volume":"28","author":"Kirby","year":"2013","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1510","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S8756-3282(99)00155-6","article-title":"Cortical tibial bone volume in two strains of mice: Effects of sciatic neurectomy and genetic regulation of bone response to mechanical loading","volume":"25","author":"Kodama","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1515","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000181921","article-title":"Effect of prolactin on the secretion of hypothalamic gnrh and pituitary gonadotropins","volume":"35","author":"Koike","year":"1991","journal-title":"Hormone Research in P\u00e6diatrics"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1520","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/cs0940405","article-title":"Bone mineral changes during pregnancy and lactation: A longitudinal cohort study","volume":"94","author":"Kolthoff","year":"1998","journal-title":"Clinical Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1525","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00441-012-1546-x","article-title":"Functions of the osteocyte network in the regulation of bone mass","volume":"352","author":"Komori","year":"2013","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1530","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2015.03.028","article-title":"Animal models for osteoporosis","volume":"759","author":"Komori","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1535","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00223-009-9281-3","article-title":"Effect of the vitamin D receptor on bone geometry and strength during gestation and lactation in mice","volume":"85","author":"Korecki","year":"2009","journal-title":"Calcified Tissue International"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1540","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.00027.2015","article-title":"Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery","volume":"96","author":"Kovacs","year":"2016","journal-title":"Physiological Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1545","first-page":"832","article-title":"Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation","volume":"18","author":"Kovacs","year":"1997","journal-title":"Endocrine Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1550","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/ajcn\/65.6.1738","article-title":"Bone mineral density changes during lactation: Maternal, dietary, and biochemical correlates","volume":"65","author":"Krebs","year":"1997","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1555","first-page":"55","article-title":"The influence of immobilization on osteocyte morphology - osteocyte differential count and electron microscopical studies","volume":"370","author":"Krempien","year":"1976","journal-title":"Virchows Archiv. A, Pathological Anatomy and Histology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1560","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/cs0640537","article-title":"Vertebral Bone loss: An unheeded side effect of therapeutic bed rest","volume":"64","author":"Kr\u00f8lner","year":"1983","journal-title":"Clinical Science"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1565","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/628740","article-title":"Evidence for the adverse effect of starvation on bone quality: a review of the literature","volume":"2015","author":"Kueper","year":"2015","journal-title":"International Journal of Endocrinology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1570","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02556673","article-title":"Interrelationships of bone ash and whole bone properties in the lactating and parous rat","volume":"41","author":"Kusy","year":"1987","journal-title":"Calcified Tissue International"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1575","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1580","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.702261","article-title":"Osteoporosis-related randomized clinical trials with middle-aged and older adults registered on the international clinical trials registry platform","volume":"12","author":"Lai","year":"2021","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1585","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1359\/jbmr.2003.18.3.393","article-title":"Growth hormone increases bone mineral content in postmenopausal osteoporosis: A randomized placebo-controlled trial","volume":"18","author":"Landin-Wilhelmsen","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1590","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/jsbi.1993.1003","article-title":"Mineral and organic matrix interaction in normally calcifying tendon visualized in three dimensions by high-voltage electron microscopic tomography and graphic image reconstruction","volume":"110","author":"Landis","year":"1993","journal-title":"Journal of Structural Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1595","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1359\/JBMR.051103","article-title":"Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice","volume":"21","author":"Lane","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1600","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/bph.15024","article-title":"Overview of treatment approaches to osteoporosis","volume":"178","author":"Langdahl","year":"2021","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1605","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.wem.2020.09.002","article-title":"The death zone: Lessons from history","volume":"32","author":"Lankford","year":"2021","journal-title":"Wilderness & Environmental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1610","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13395-015-0060-8","article-title":"Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice","volume":"5","author":"Latres","year":"2015","journal-title":"Skeletal Muscle"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb1615","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between Dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1620","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jbmr.3930","article-title":"Abaloparatide at the same dose has the same effects on bone as PTH (1-34) in mice","volume":"35","author":"Le Henaff","year":"2020","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1625","first-page":"335","article-title":"Alendronate as an effective countermeasure to disuse induced bone loss","volume":"2","author":"LeBlanc","year":"2002","journal-title":"Journal of Musculoskeletal & Neuronal Interactions"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1630","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2009-0206","article-title":"The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men","volume":"94","author":"LeBlanc","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1635","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.1041460306","article-title":"Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures","volume":"146","author":"Leboy","year":"1991","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1640","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2002-021036","article-title":"Differential effects of androgens and estrogens on bone turnover in normal men","volume":"88","author":"Leder","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6947","key":"10.1016\/j.pharmthera.2023.108383_bb1645","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/424389a","article-title":"Bone adaptation requires oestrogen receptor-\u03b1","volume":"424","author":"Lee","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1650","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/excr.1998.4071","article-title":"Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+","volume":"242","author":"Lehenkari","year":"1998","journal-title":"Experimental Cell Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1655","first-page":"424","article-title":"The laboratory rat as an animal model for osteoporosis research","volume":"58","author":"Lelovas","year":"2008","journal-title":"Comparative Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1660","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJM199303043280917","article-title":"Hypercalcemia in pregnancy and lactation associated with parathyroid hormone-related protein","volume":"328","author":"Lepre","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1665","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00198-018-4414-z","article-title":"Estrogen therapy for osteoporosis in the modern era","volume":"29","author":"Levin","year":"2018","journal-title":"Osteoporosis International"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1670","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1017\/S000711451600060X","article-title":"Effect of chronic undernutrition on body mass and mechanical bone quality under normoxic and altitude hypoxic conditions","volume":"115","author":"Lezon","year":"2016","journal-title":"British Journal of Nutrition"},{"issue":"2566","key":"10.1016\/j.pharmthera.2023.108383_bb1675","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.99.2566.183","article-title":"The isolation of pituitary growth hormone","volume":"99","author":"Li","year":"1944","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb1680","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.bbadis.2017.07.036","article-title":"Upregulation of Akt signaling enhances femoral fracture healing by accelerating atrophic quadriceps recovery","volume":"1863","author":"Li","year":"2017","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jot.2021.11.009","article-title":"A mouse model of disuse osteoporosis based on a movable noninvasive 3D-printed unloading device","volume":"33","author":"Li","year":"2022","journal-title":"Journal of Orthopaedic Translation"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1690","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49631","article-title":"Stimulation of piezo1 by mechanical signals promotes bone anabolism","volume":"8","author":"Li","year":"2019","journal-title":"ELife"},{"issue":"45","key":"10.1016\/j.pharmthera.2023.108383_bb1695","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M705194200","article-title":"Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis","volume":"282","author":"Li","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108383_bb1700","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108383_bb1705","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1710","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/\u03b2-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1715","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00223-014-9899-7","article-title":"Glucocorticoid-induced osteoporosis in growing rats","volume":"95","author":"Lin","year":"2014","journal-title":"Calcified Tissue International"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108383_bb1720","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3390\/jcm10143043","article-title":"Efficacy and safety of postmenopausal osteoporosis treatments: A systematic review and network meta-analysis of randomized controlled trials","volume":"10","author":"Lin","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1725","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/0019-5413.185606","article-title":"Relation between the development of osteoporosis and osteonecrosis following glucocorticoid in a rabbit model","volume":"50","author":"Lin","year":"2016","journal-title":"Indian Journal of Orthopaedics"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1730","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00757","article-title":"The Bone extracellular matrix in Bone formation and regeneration","volume":"11","author":"Lin","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1735","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1009905808033","article-title":"Cushing\u2019s syndrome: Historical aspects","volume":"3","author":"Lindholm","year":"2000","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","article-title":"Structure and mechanism of carbonic anhydrase","volume":"74","author":"Lindskog","year":"1997","journal-title":"Pharmacology and Therapeutics"},{"issue":"6072","key":"10.1016\/j.pharmthera.2023.108383_bb1745","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/321779a0","article-title":"Pituitary FSH is released by a heterodimer of the \u03b2-subunits from the two forms of inhibin","volume":"321","author":"Ling","year":"1986","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1750","first-page":"1","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1755","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/jbmr.1503","article-title":"Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice","volume":"27","author":"Liu","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1760","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/235060","article-title":"Effect of GH\/IGF-1 on Bone metabolism and Osteoporsosis","volume":"2014","author":"Locatelli","year":"2014","journal-title":"International Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.04.001","article-title":"Principles of the activin receptor signaling pathway and its inhibition","volume":"60","author":"Lodberg","year":"2021","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1770","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bone.2018.02.026","article-title":"A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia","volume":"110","author":"Lodberg","year":"2018","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1775","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1096\/fj.201801969RR","article-title":"A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice","volume":"33","author":"Lodberg","year":"2019","journal-title":"FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1780","article-title":"Hot to touch: The story of the 2021 nobel prize in physiology or medicine","volume":"14","author":"Logan","year":"2021","journal-title":"DMM Disease Models and Mechanisms"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1785","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01623940","article-title":"Bone turnover and density in healthy women during breastfeeding and after weaning","volume":"6","author":"L\u00f3pez","year":"1996","journal-title":"Osteoporosis International"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1790","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bone.2010.01.370","article-title":"A soluble activin receptor type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys","volume":"46","author":"Lotinun","year":"2010","journal-title":"Bone"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108383_bb1795","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.febslet.2014.04.012","article-title":"YAP\/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth","volume":"588","author":"Low","year":"2014","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1800","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-857X(05)70192-7","article-title":"The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis","volume":"27","author":"Lufkin","year":"2001","journal-title":"Rheumatic Disease Clinics of North America"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1805","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.wem.2019.04.006","article-title":"Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update","volume":"30","author":"Luks","year":"2019","journal-title":"Wilderness & Environmental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1810","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/dbio.2000.9975","article-title":"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth","volume":"229","author":"Lupu","year":"2001","journal-title":"Developmental Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1815","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamainternmed.2019.5679","article-title":"Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation","volume":"180","author":"Lutsey","year":"2020","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1820","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.5650100322","article-title":"Human parathyroid hormone-(1\u201338) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats","volume":"10","author":"Ma","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1825","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S1357-2725(03)00107-9","article-title":"Osteoblasts: Novel roles in orchestration of skeletal architecture","volume":"35","author":"Mackie","year":"2003","journal-title":"International Journal of Biochemistry and Cell Biology"},{"issue":"D1","key":"10.1016\/j.pharmthera.2023.108383_bb1830","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr1061","article-title":"Mouse phenome database (MPD)","volume":"40","author":"Maddatu","year":"2012","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1835","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00223-009-9303-1","article-title":"Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells","volume":"85","author":"Mak","year":"2009","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1840","article-title":"Frequent administration of abaloparatide shows greater gains in bone anabolic window and bone mineral density in mice: A comparison with teriparatide","volume":"142","author":"Makino","year":"2020","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb1845","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nature Reviews Endocrinology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb1850","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.287","article-title":"Osteoblastic heparan sulfate glycosaminoglycans control bone remodeling by regulating Wnt signaling and the crosstalk between bone surface and marrow cells","volume":"8","author":"Mansouri","year":"2017","journal-title":"Cell Death & Disease"},{"issue":"4 (14\/4)","key":"10.1016\/j.pharmthera.2023.108383_bb1855","article-title":"Bone changes due to pregnancy and lactation: Influence of vitamin D status","volume":"251","author":"Marie","year":"1986","journal-title":"American Journal of Physiology - Endocrinology and Metabolism"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb1860","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tem.2014.06.009","article-title":"Integrin and cadherin signaling in bone: Role and potential therapeutic targets","volume":"25","author":"Marie","year":"2014","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1865","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40265-019-01072-6","article-title":"Romosozumab: First global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"issue":"1 Supplement","key":"10.1016\/j.pharmthera.2023.108383_bb1870","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/BF01673402","article-title":"A new theory of bone lamellation","volume":"53","author":"Marotti","year":"1993","journal-title":"Calcified Tissue International"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1875","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb1880","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/stem.2474","article-title":"Quiescent bone lining cells are a major source of osteoblasts during adulthood","volume":"34","author":"Matic","year":"2016","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1885","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1890","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1895","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb1900","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: Results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT extension study","volume":"7","author":"McClung","year":"2019","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb1905","first-page":"491","article-title":"Anatomy of a physiological discovery: William Harvey and the circulation of the blood","volume":"88","author":"McMullen","year":"1995","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1910","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/endo-118-2-824","article-title":"Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone","volume":"118","author":"McSheehy","year":"1986","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb1915","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1359\/jbmr.080518","article-title":"Older men with low serum estradiol and high serum SHBG have an increased risk of fractures","volume":"23","author":"Mellstr\u00f6m","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-019-0045-z","article-title":"Hypoxia-inducible factor 2\u03b1 is a negative regulator of osteoblastogenesis and bone mass accrual","volume":"7","author":"Merceron","year":"2019","journal-title":"Bone Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb1925","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00003086-197110000-00021","article-title":"Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies","volume":"80","author":"Meunier","year":"1971","journal-title":"Clinical Orthopaedics and Related Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb1930","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1935","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/8756-3282(89)90065-3","article-title":"Increased cancellous bone remodeling during lactation in beagles","volume":"10","author":"Miller","year":"1989","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb1940","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1945","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ar.20403","article-title":"Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation","volume":"290","author":"Miller","year":"2007","journal-title":"Anatomical Record"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1950","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/8756-3282(86)90209-7","article-title":"Changes in bone mineral and bone formation rates during pregnancy and lactation in rats","volume":"7","author":"Miller","year":"1986","journal-title":"Bone"},{"issue":"4038","key":"10.1016\/j.pharmthera.2023.108383_bb1955","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.176.4038.1031","article-title":"Carbonic anhydrase and bone remodeling: Sulfonamide inhibition of bone resorption in organ culture","volume":"176","author":"Minkin","year":"1972","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108383_bb1960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21217989","article-title":"No role of osteocytic osteolysis in the development and recovery of the bone phenotype induced by severe secondary hyperparathyroidism in vitamin D receptor deficient mice","volume":"21","author":"Misof","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1965","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/endo-116-2-813","article-title":"Age-correlated and ovary-dependent changes in relationships between plasma estradiol and luteinizing hormone, prolactin, and growth hormone in female C57BL\/6J mice","volume":"116","author":"Mobbs","year":"1985","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb1970","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men","volume":"26","author":"M\u00f6dder","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1975","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7150\/ijms.22732","article-title":"Establishing an animal model of secondary osteoporosis by using a gonadotropin-releasing hormone agonist","volume":"15","author":"Mohamad","year":"2018","journal-title":"International Journal of Medical Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb1980","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1677\/JOE-08-0532","article-title":"Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats","volume":"202","author":"Mohamed","year":"2009","journal-title":"Journal of Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb1985","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/en.2002-220948","article-title":"Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms","volume":"144","author":"Mohan","year":"2003","journal-title":"Endocrinology"},{"issue":"23","key":"10.1016\/j.pharmthera.2023.108383_bb1990","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb1995","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00198-011-1654-6","article-title":"Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study","volume":"23","author":"M\u00f8ller","year":"2012","journal-title":"Osteoporosis International"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2000","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1152\/japplphysiol.00969.2001","article-title":"Hindlimb unloading rodent model: Technical aspects","volume":"92","author":"Morey-Holton","year":"2002","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1569-2574(05)10002-1","article-title":"The Hindlimb unloading rat model: Literature overview, technique update and comparison with space flight data","volume":"10","author":"Morey-Holton","year":"2005","journal-title":"Advances in Space Biology and Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jcp.25399","article-title":"Glucocorticoids hijack Runx2 to stimulate Wif1 for suppression of osteoblast growth and differentiation","volume":"232","author":"Morimoto","year":"2017","journal-title":"Journal of Cellular Physiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","article-title":"The M-CSF receptor in osteoclasts and beyond","volume":"52","author":"Mun","year":"2020","journal-title":"Experimental and Molecular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00024677-200403020-00006","article-title":"Calcitonin therapy in osteoporosis","volume":"3","author":"Mu\u00f1oz-Torres","year":"2004","journal-title":"Treatments in Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands","volume":"26","author":"Murray","year":"2005","journal-title":"Endocrine Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb2030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108383_bb2040","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/life4040621","article-title":"Microgravity-induced fluid shift and ophthalmic changes","volume":"4","author":"Nelson","year":"2014","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2050","first-page":"804","article-title":"Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL\/6J mice","volume":"130","author":"Nelson","year":"1992","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb2055","first-page":"3483","article-title":"Expression of functional growth hormone receptors in cultured human osteoblast-like cells","volume":"80","author":"Nilsson","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1359\/jbmr.091020","article-title":"Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: An in vivo HR-pQCT study","volume":"25","author":"Nishiyama","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2065","article-title":"Human physiological and metabolic responses to an attempted winter crossing of Antarctica: The effects of prolonged hypobaric hypoxia","volume":"6","author":"O\u2019Brien","year":"2018","journal-title":"Physiological Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/s10165-008-0096-2","article-title":"Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry","volume":"18","author":"Ogoshi","year":"2008","journal-title":"Modern Rheumatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.55460\/5JV1-0FIP","article-title":"The use of dexamethasone in support of high-altitude ground operations and physical performance: Review of the literature","volume":"14","author":"O\u2019Hara","year":"2014","journal-title":"Journal of Special Operations Medicine"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2147\/TCRM.S149236","article-title":"Minodronate for the treatment of osteoporosis","volume":"14","author":"Ohishi","year":"2018","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2085","first-page":"55","article-title":"Growth hormone and bone","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2005.01.117","article-title":"Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts","volume":"329","author":"Ohnaka","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2009.04010.x","article-title":"Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis","volume":"158","author":"Okano","year":"2009","journal-title":"Clinical and Experimental Immunology"},{"issue":"4 SUPPL","key":"10.1016\/j.pharmthera.2023.108383_bb2100","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/8756-3282(95)00329-C","article-title":"The effect of ovariectomy on bone metabolism in rats","volume":"17","author":"Omi","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bone.2015.08.007","article-title":"Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats","volume":"81","author":"Ominsky","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: Bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflammation and Regeneration"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i2.20","article-title":"Estrogen regulation of gene expression in osteoblasts and osteoclasts","volume":"8","author":"Oursler","year":"1998","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"issue":"OCT","key":"10.1016\/j.pharmthera.2023.108383_bb2120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fbioe.2018.00134","article-title":"In vitro models of bone remodelling and associated disorders","volume":"6","author":"Owen","year":"2018","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2006.01.142","article-title":"The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment","volume":"39","author":"Oxlund","year":"2006","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1515\/BC.2006.128","article-title":"Functional responses of bone cells to thrombin","volume":"387","author":"Pagel","year":"2006","journal-title":"Biological Chemistry"},{"issue":"127","key":"10.1016\/j.pharmthera.2023.108383_bb2135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00003086-197709000-00036","article-title":"The cellular basis of bone turnover and bone loss. A rebuttal of the osteocytic resorption, bone flow theory","volume":"127","author":"Parfitt","year":"1977","journal-title":"Clinical Orthopaedics and Related Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0221-8747(82)90002-9","article-title":"The coupling of bone formation to bone resorption: A critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis","volume":"4","author":"Parfitt","year":"1982","journal-title":"Metabolic Bone Disease & Related Research"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/8415_2011_113","article-title":"Characterisation of trabecular bone structure","volume":"5","author":"Parkinson","year":"2013","journal-title":"Studies in Mechanobiology, Tissue Engineering and Biomaterials"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb2150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040634","article-title":"Acceptability of bisphosphonates among patients, clinicians and managers: A systematic review and framework synthesis","volume":"10","author":"Paskins","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0185(199712)249:4<458::AID-AR5>3.0.CO;2-N","article-title":"Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment","volume":"249","author":"Pataki","year":"1997","journal-title":"Anatomical Record"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108383_bb2160","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1073\/pnas.0711263105","article-title":"A soluble activin type IIA receptor induces bone formation and improves skeletal integrity","volume":"105","author":"Pearsall","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-47818-w","article-title":"Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease","volume":"9","author":"Pearsall","year":"2019","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bone.2003.11.005","article-title":"Recovery of pregnancy mediated bone loss during lactation","volume":"34","author":"Pearson","year":"2004","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2175","first-page":"293","article-title":"Effect of number of suckling pups and dietary calcium on bone mineral content and mechanical properties of femurs of lactating rats","volume":"3","author":"Peng","year":"1988","journal-title":"Bone and Mineral"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jbmr.5650020312","article-title":"Influence of lactation and pregnancy + lactation on mechanical properties and mineral content of the rat femur","volume":"2","author":"Peng","year":"1987","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2185","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","article-title":"Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice","volume":"311","author":"Piemontese","year":"2016","journal-title":"American Journal of Physiology - Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2190","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.5650060406","article-title":"Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women","volume":"6","author":"Pierce","year":"1991","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2195","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00774-010-0254-4","article-title":"Aluminum bone toxicity in immature rats exposed to simulated high altitude","volume":"29","author":"del Pilar Mart\u00ednez","year":"2011","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"5411","key":"10.1016\/j.pharmthera.2023.108383_bb2200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.pharmthera.2023.108383_bb2205","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M611435200","article-title":"Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival: Evidence for inside-out signaling leading to anoikis","volume":"282","author":"Plotkin","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb2210","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2215","first-page":"52","article-title":"Bone mineral changes during and after lactation","volume":"94","author":"Polatti","year":"1999","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.201802-0286OC","article-title":"Activin type II receptor blockade for treatment of muscle depletion in chronic obstructive pulmonary disease: A randomized trial","volume":"199","author":"Polkey","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2015.973021","article-title":"Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis","volume":"24","author":"Polyzos","year":"2015","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"APR","key":"10.1016\/j.pharmthera.2023.108383_bb2230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fendo.2019.00236","article-title":"Updates on osteoimmunology: What\u2019s new on the cross-talk between bone and immune system","volume":"10","author":"Ponzetti","year":"2019","journal-title":"Frontiers in Endocrinology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2235","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00223-009-9301-3","article-title":"Glucocorticoid-induced osteoporosis in growing mice is not prevented by simultaneous intermittent PTH treatment","volume":"85","author":"Postnov","year":"2009","journal-title":"Calcified Tissue International"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF02973285","article-title":"The biomechanics of Wolff\u2019s law: Recent advances","volume":"164","author":"Prendergast","year":"1995","journal-title":"Irish Journal of Medical Science"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-2895-8_14","article-title":"Glucocorticoids and cancer","volume":"872","author":"Pufall","year":"2015","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2018","journal-title":"Nature Reviews Drug Discovery"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2255","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.biocel.2012.05.014","article-title":"V-ATPases in osteoclasts: Structure, function and potential inhibitors of bone resorption","volume":"44","author":"Qin","year":"2012","journal-title":"International Journal of Biochemistry and Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41413-020-0099-y","article-title":"Molecular mechanosensors in osteocytes","volume":"8","author":"Qin","year":"2020","journal-title":"Bone Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb2265","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00198-016-3700-x","article-title":"Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury","volume":"27","author":"Qin","year":"2016","journal-title":"Osteoporosis International"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2270","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2275","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4248\/ijos.09019","article-title":"Osteocyte remodeling of the perilacunar and pericanalicular matrix","volume":"1","author":"Qing","year":"2009","journal-title":"International Journal of Oral Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2280","doi-asserted-by":"crossref","first-page":"E1077","DOI":"10.1152\/ajpendo.2006.263.6.E1077","article-title":"Production of parathyroid hormone-related protein by the rat mammary gland in pregnancy and lactation","volume":"263","author":"Rakopoulos","year":"2006","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb2285","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1359\/jbmr.1999.14.11.1934","article-title":"Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model","volume":"14","author":"Rantakokko","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02012772","article-title":"Calcium deficiency, pregnancy, and lactation in rats - microscopic and microradiographic observations on bones","volume":"23","author":"Rasmussen","year":"1977","journal-title":"Calcified Tissue Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporosis International"},{"issue":"9671","key":"10.1016\/j.pharmthera.2023.108383_bb2305","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): A multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-4615-4711-2_23","article-title":"Operation Everest III (COMEX \u201897): Effects of prolonged and progressive hypoxia on humans during a smulated ascent to 8,848 m in a hypobaric chamber","volume":"474","author":"Richalet","year":"2000","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2315","first-page":"419","article-title":"Recherches exp\u00e9rimentales sur la formation du cal et sur les modifications des tissus dans les pseudoarthroses","volume":"8","author":"Rigal","year":"1881","journal-title":"Archives of Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2320","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bone.2006.11.028","article-title":"Membrane-bound carbonic anhydrases in osteoclasts","volume":"40","author":"Riihonen","year":"2007","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb2325","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/ja01167a011","article-title":"The preparation of heterocyclic sulfonamides","volume":"72","author":"Roblin","year":"1950","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2019.12.014","article-title":"Inhibitory effects of dabigatran etexilate, a direct thrombin inhibitor, on osteoclasts and osteoblasts","volume":"186","author":"Rocha","year":"2020","journal-title":"Thrombosis Research"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108383_bb2335","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2340","first-page":"1","article-title":"Disuse osteoporosis: Clinical and mechanistic insights","volume":"1","author":"Rolvien","year":"2021","journal-title":"Calcified Tissue International"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2023.108383_bb2345","article-title":"Cytokines in the pathogenesis of osteoporosis","volume":"7","author":"Romas","year":"1997","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.613435","article-title":"A glance at the use of glucocorticoids in rare inflammatory and autoimmune diseases: Still an indispensable pharmacological tool?","volume":"11","author":"Ronchetti","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2355","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: Results from a phase II, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncprheum0070","article-title":"Mechanisms of disease: Is osteoporosis the obesity of bone?","volume":"2","author":"Rosen","year":"2006","journal-title":"Nature Clinical Practice Rheumatology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2365","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jbmr.5650100912","article-title":"Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density","volume":"10","author":"Rosen","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2370","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1359\/jbmr.081208","article-title":"Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgGl) in postmenopausal women","volume":"24","author":"Ruckle","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2375","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: The first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"7740","key":"10.1016\/j.pharmthera.2023.108383_bb2380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(72)90004-9","article-title":"Treatment of myositis ossificans progressiva with a diphosphonate","volume":"299","author":"Russell","year":"1972","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.12659\/MSMBR.901142","article-title":"Osteoblast differentiation at a glance","volume":"22","author":"Rutkovskiy","year":"2016","journal-title":"Medical Science Monitor Basic Research"},{"issue":"4 FEB","key":"10.1016\/j.pharmthera.2023.108383_bb2390","article-title":"The discovery of dabigatran etexilate","author":"van Ryn","year":"2013","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2395","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb2400","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.40874","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: Final results of a twenty-four\u2013month randomized, double-blind, double-dummy trial","volume":"71","author":"Saag","year":"2019","journal-title":"Arthritis and Rheumatology"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108383_bb2405","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108383_bb2410","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108383_bb2415","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14225","article-title":"Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and \u03b2-arrestin recruitment than teriparatide","volume":"7","author":"Sahbani","year":"2019","journal-title":"Physiological Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2420","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S8756-3282(03)00088-7","article-title":"Skeletal unloading induces resistance to insulin-like growth factor I on bone formation","volume":"32","author":"Sakata","year":"2003","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb2425","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jbmr.2869","article-title":"Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of sost\/sclerostin","volume":"31","author":"Sato","year":"2016","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2430","first-page":"664","article-title":"Glucocorticoids induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases","volume":"158","author":"Sato","year":"2017","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2435","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2440","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ame2.12083","article-title":"Animal modeling in bone research\u2014Should we follow the white rabbit?","volume":"2","author":"Schafrum Macedo","year":"2019","journal-title":"Animal Models and Experimental Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2445","first-page":"160","article-title":"Effects of recombinant human insulin-like growth factor I and II (IGF-I\/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells","volume":"1","author":"Scheven","year":"1991","journal-title":"Growth Regulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2450","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00198-013-2280-2","article-title":"Acute response to oral calcium loading in pregnant and lactating women with a low calcium intake: A pilot study","volume":"24","author":"Schoenmakers","year":"2013","journal-title":"Osteoporosis International"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2455","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/endo-16-5-547","article-title":"On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol","volume":"16","author":"Selye","year":"1932","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2460","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1091\/mbc.5.5.565","article-title":"Adhesive properties of osteopontin: Regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain","volume":"5","author":"Senger","year":"1994","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2017.03.040","article-title":"Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome","volume":"99","author":"Shapiro","year":"2017","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb2470","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jcph.160","article-title":"Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a Novel erythropoietic agent, in healthy postmenopausal women","volume":"53","author":"Sherman","year":"2013","journal-title":"Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2475","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/JME-14-0314","article-title":"Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling","volume":"54","author":"Shi","year":"2015","journal-title":"Journal of Molecular Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2480","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2485\/jhtb.16.115","article-title":"Effects of carbonic anhydrase inhibitor acetazolamide (AZ) on osteoclasts and bone structure","volume":"16","author":"Shinohara","year":"2007","journal-title":"Journal of Hard Tissue Biology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb2485","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s40265-017-0780-7","article-title":"Abaloparatide: First global approval","volume":"77","author":"Shirley","year":"2017","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb2490","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/en.2006-0089","article-title":"Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins","volume":"147","author":"Sidis","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: Anabolic and catabolic actions on the skeleton","volume":"Vol. 22","author":"Silva","year":"2015","journal-title":"Current Opinion in Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2500","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10735-007-9096-3","article-title":"Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone","volume":"38","author":"Silvestrini","year":"2007","journal-title":"Journal of Molecular Histology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2505","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1359\/JBMR.041233","article-title":"Influence of glucocorticoids on human osteoclast generation and activity","volume":"20","author":"Sivagurunathan","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2510","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/JME-12-0177","article-title":"Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism","volume":"50","author":"Sivagurunathan","year":"2013","journal-title":"Journal of Molecular Endocrinology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb2515","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI119701","article-title":"Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens","volume":"100","author":"Slemenda","year":"1997","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2520","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1677\/joe.0.1500465","article-title":"Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: Modulation by retinoic acid and cell differentiation","volume":"150","author":"Slootweg","year":"1996","journal-title":"Journal of Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2525","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0006-291X(87)80202-4","article-title":"Role of kinase C in the insulin-like effects of human growth hormone in rat adipocytes","volume":"147","author":"Smal","year":"1987","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9581-3_1","article-title":"The rat: A model used in biomedical research","volume":"2018","author":"Smith","year":"2019","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115183","article-title":"Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice","volume":"131","author":"S\u00f8rensen","year":"2020","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2540","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jocd.2005.11.005","article-title":"Inhaled steroids do not decrease bone mineral density but increase risk of fractures: Data from the GIUMO Study Group","volume":"9","author":"Sosa","year":"2006","journal-title":"Journal of Clinical Densitometry"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb2545","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1996.03540070045029","article-title":"Elevated parathyroid hormone-related peptide associated with lactation and bone density loss","volume":"276","author":"Sowers","year":"1996","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2550","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/ajcn\/67.2.284","article-title":"Role of calciotrophic hormones in calcium mobilization of lactation","volume":"67","author":"Sowers","year":"1998","journal-title":"American Journal of Clinical Nutrition"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb2555","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.prp.2007.08.002","article-title":"Renal failure in high altitude: Renal functions, renal pathology and bone mineralization in rats with ablation nephropathy at 1200 m altitude","volume":"203","author":"Soylu","year":"2007","journal-title":"Pathology Research and Practice"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2560","doi-asserted-by":"crossref","first-page":"E1736","DOI":"10.1210\/jc.2012-1579","article-title":"Serum sclerostin increases in healthy adult men during bed rest","volume":"97","author":"Spatz","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"27","key":"10.1016\/j.pharmthera.2023.108383_bb2565","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"1_suppl","key":"10.1016\/j.pharmthera.2023.108383_bb2570","doi-asserted-by":"crossref","first-page":"09S","DOI":"10.1177\/1076029609343004","article-title":"Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor","volume":"15","author":"Stangier","year":"2009","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04679-7","article-title":"Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin","volume":"9","author":"Stegen","year":"2018","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2580","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1084952102000587","article-title":"Formation and function of the ruffled border in osteoclasts","volume":"13","author":"Stenbeck","year":"2002","journal-title":"Seminars in Cell and Developmental Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2585","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3899\/jrheum.081207","article-title":"Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: A 12-month randomized, placebo-controlled clinical trial","volume":"36","author":"Stoch","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108383_bb2590","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis","volume":"322","author":"Storm","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2595","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: Viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2600","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","article-title":"Glucocorticoids-all-rounders tackling the versatile players of the immune system","volume":"10","author":"Strehl","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2605","doi-asserted-by":"crossref","DOI":"10.1038\/srep30186","article-title":"Mesenchymal progenitors in osteopenias of diverse pathologies: Differential characteristics in the common shift from osteoblastogenesis to adipogenesis","volume":"6","author":"Sui","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2610","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47454","article-title":"The mechanosensitive Piezo1 channel is required for bone formation","volume":"8","author":"Sun","year":"2019","journal-title":"ELife"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108383_bb2615","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochemical Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2620","first-page":"192","article-title":"Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study 1","volume":"86","author":"Szulc","year":"2001","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108383_bb2625","doi-asserted-by":"crossref","first-page":"16699","DOI":"10.1074\/jbc.M114.547919","article-title":"Age-related marrow adipogenesis is linked to increased expression of RANKL","volume":"289","author":"Takeshita","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2630","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040984","article-title":"The sealing zone in osteoclasts: A self-organized structure on the bone","volume":"19","author":"Takito","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2635","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00302665","article-title":"Relative glucocorticoid potency revisited","volume":"14","author":"Tanaka","year":"1994","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2640","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02383459","article-title":"Bone atrophy at high altitude","volume":"10","author":"Tanaka","year":"1992","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2645","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00774-020-01176-0","article-title":"Sclerostin: From bench to bedside","volume":"39","author":"Tanaka","year":"2021","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb2650","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1359\/jbmr.1998.13.10.1555","article-title":"Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections","volume":"13","author":"Tanaka-Kamioka","year":"1998","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2655","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/toxins13030213","article-title":"Botulinum toxin A and osteosarcopenia in experimental animals: A scoping review","volume":"13","author":"Tang","year":"2021","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2660","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2665","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2015.12.013","article-title":"Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats","volume":"84","author":"Taylor","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2670","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115801","article-title":"Abaloparatide treatment increases bone formation, bone density and bone strength without increasing bone resorption in a rat model of hindlimb unloading","volume":"144","author":"Teguh","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0738-7","article-title":"Wolff\u2019s law in action: A mechanism for early knee osteoarthritis","volume":"17","author":"Teichtahl","year":"2015","journal-title":"Arthritis Research and Therapy"},{"issue":"5484","key":"10.1016\/j.pharmthera.2023.108383_bb2680","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2685","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","article-title":"Osteoclasts: What do they do and how do they do it?","volume":"170","author":"Teitelbaum","year":"2007","journal-title":"American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2690","article-title":"Profile of abaloparatide and its potential in the treatment of postmenopausal osteoporosis","volume":"9","author":"Tella","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2695","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1749-6632.2009.05243.x","article-title":"Osteocyte primary cilium and its role in bone mechanotransduction","volume":"1192","author":"Temiyasathit","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2700","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2008.09.017","article-title":"Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited","volume":"44","author":"Teti","year":"2009","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2705","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/mol.105.020776","article-title":"Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis","volume":"69","author":"Thompson","year":"2006","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2710","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","article-title":"Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model","volume":"48","author":"Tian","year":"2011","journal-title":"Bone"},{"issue":"1 I","key":"10.1016\/j.pharmthera.2023.108383_bb2715","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9378(98)70649-0","article-title":"Bone structural and metabolic changes at the end of pregnancy and lactation in rats","volume":"178","author":"Tojo","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2720","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/JME-11-0165","article-title":"Involvement of AMP-activated protein kinase in thrombin-stimulated interleukin 6 synthesis in osteoblasts","volume":"49","author":"Tokuda","year":"2012","journal-title":"Journal of Molecular Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2725","first-page":"209","article-title":"Osteopetrosis with syndactyly; a morphological variant of Albers-Sch\u00f6nberg\u2019s disease","volume":"40 B","author":"Truswell","year":"1958","journal-title":"The Journal of Bone and Joint Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2730","first-page":"92","article-title":"Osteoporosis: A review of treatment options","volume":"43","author":"Tu","year":"2018","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2735","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bone.2014.11.004","article-title":"Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL\/OPG ratio","volume":"72","author":"Tudpor","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2740","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1359\/jbmr.061006","article-title":"Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats","volume":"22","author":"Turner","year":"2007","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2745","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2750","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/endo.136.8.7628353","article-title":"Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo","volume":"136","author":"Uy","year":"1995","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2755","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1095\/biolreprod65.3.689","article-title":"Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat","volume":"65","author":"Vajda","year":"2001","journal-title":"Biology of Reproduction"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2760","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/eje.0.1400545","article-title":"Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults","volume":"140","author":"V\u00e4lim\u00e4ki","year":"1999","journal-title":"European Journal of Endocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2765","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2146\/ajhp170279","article-title":"Evaluating off-label uses of acetazolamide","volume":"75","author":"Van Berkel","year":"2018","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2770","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"Van Bezooijen","year":"2004","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2775","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00016925509170789","article-title":"An uncommon familial systemic disease of the skeleton: Hyperostosis corticalis generalisata familiaris","volume":"44","author":"Van Buchem","year":"1955","journal-title":"Acta Radiologica"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2780","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"Journal of Bone and Mineral Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2785","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00214682","article-title":"An electron-microscopic study of the bone-remodeling sequence in the rat","volume":"225","author":"Van Tran","year":"1982","journal-title":"Cell and Tissue Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108383_bb2790","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/1529-0131(199907)42:7<1405::AID-ANR14>3.0.CO;2-W","article-title":"Fat conversion of femoral marrow in glucocorticoid-treated patients: A cross-sectional and longitudinal study with magnetic resonance imaging","volume":"42","author":"Vande Berg","year":"1999","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2795","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ilar.41.3.133","article-title":"Use of house mice in biomedical research","volume":"41","author":"Vandenbergh","year":"2000","journal-title":"ILAR Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2800","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200319504","article-title":"Mammary-specific deletion of parathyroid hormone\u2013related protein preserves bone mass during lactation","volume":"112","author":"VanHouten","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb2805","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1210\/en.2003-0892","article-title":"Low Estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice","volume":"144","author":"Vanhouten","year":"2003","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2810","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00774-017-0830-y","article-title":"Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL\/6J mice","volume":"36","author":"Vegger","year":"2018","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2815","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00223-015-0035-0","article-title":"Vertical trabeculae are thinned more than horizontal trabeculae in skeletal-unloaded rats","volume":"97","author":"Vegger","year":"2015","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2820","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2014.06.020","article-title":"Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats","volume":"66","author":"Vegger","year":"2014","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ani11030714","article-title":"Animal models for in vivo lactation studies: Anatomy, physiology and milk compositions in the most used non-clinical species: A contribution from the conception project","volume":"11","author":"Ventrella","year":"2021","journal-title":"Animals"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2830","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jcp.55.9.693","article-title":"Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis","volume":"55","author":"Verma","year":"2002","journal-title":"Journal of Clinical Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2835","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1590191","article-title":"Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids","volume":"159","author":"Vidal","year":"1998","journal-title":"Journal of Endocrinology"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108383_bb2840","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/archinte.166.22.2502","article-title":"Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: A randomized controlled trial","volume":"166","author":"Villareal","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44620-6","article-title":"Bone mineral: New insights into its chemical composition","volume":"9","author":"Von Euw","year":"2019","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2850","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-3356(21)00436-2","article-title":"Control of hormone release during lactation","volume":"5","author":"Voogt","year":"1978","journal-title":"Clinics in Obstetrics and Gynaecology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2855","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/nau.23120","article-title":"Post-injury bladder management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury","volume":"36","author":"Wada","year":"2017","journal-title":"Neurourology and Urodynamics"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2860","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.2110047","article-title":"The impact of oral corticosteroid use on bone mineral density and vertebral fracture","volume":"166","author":"Walsh","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2865","first-page":"9397","article-title":"The hypobaric hypoxia environment impairs bone strength and quality in rats","volume":"10","author":"Wang","year":"2017","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb2870","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/ham.2019.0113","article-title":"Rosamultin attenuates acute hypobaric hypoxia-induced Bone injuries by regulation of Sclerostin and its downstream signals","volume":"21","author":"Wang","year":"2020","journal-title":"High Altitude Medicine and Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2875","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/BF00340329","article-title":"Fine structure of the osteocyte capsule and of the wall of the lacunae in bone","volume":"67","author":"Wassermann","year":"1965","journal-title":"Zeitschrift f\u00fcr Zellforschung und Mikroskopische Anatomie"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2880","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2885","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jht.2011.08.003","article-title":"Specialized connective tissue: Bone, the structural framework of the upper extremity","volume":"25","author":"Weatherholt","year":"2012","journal-title":"Journal of Hand Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2890","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bone.2013.01.004","article-title":"Studying osteocytes within their environment","volume":"54","author":"Webster","year":"2013","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2895","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108383_bb2900","first-page":"2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2905","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/wdev.86","article-title":"The TGFbeta superfamily signaling pathway","volume":"2","author":"Weiss","year":"2013","journal-title":"Wiley Interdisciplinary Reviews: Developmental Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb2910","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: An inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2915","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bone.2016.03.012","article-title":"Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice","volume":"87","author":"Wendelboe","year":"2016","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb2920","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1210\/jc.2003-030201","article-title":"Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal","volume":"88","author":"Wergedal","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb2925","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-141-10-200411160-00010","article-title":"The physiologic basis of high-altitude diseases","volume":"141","author":"West","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2930","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/icb\/icj005","article-title":"Human responses to extreme altitudes","volume":"46","author":"West","year":"2006","journal-title":"Integrative and Comparative Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb2935","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1538-7836.2007.02526.x","article-title":"Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis","volume":"5","author":"Wienen","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2940","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1474-4422(09)70014-6","article-title":"The cerebral effects of ascent to high altitudes","volume":"8","author":"Wilson","year":"2009","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2945","series-title":"No signature of osteocytic osteolysis in cortical bone from lactating NMRI mice","author":"Wittig","year":"2019"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2950","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0300-9629(74)90554-4","article-title":"Effect of low calcium diet on bone and calcium metabolism in rats and mice-A differential species response","volume":"49","author":"Wolinsky","year":"1974","journal-title":"Comparative Biochemistry and Physiology -- Part A: Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2955","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02008233","article-title":"Mechanical strength and mineral content of bone from rats fed acetazolamide","volume":"16","author":"Wolinsky","year":"1974","journal-title":"Calcified Tissue Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2960","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-17-0361","article-title":"Animal models to explore the effects of glucocorticoids on skeletal growth and structure","volume":"236","author":"Wood","year":"2018","journal-title":"Journal of Endocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2965","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1210\/en.2005-1616","article-title":"Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation","volume":"147","author":"Woodrow","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb2970","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/8756-3282(89)90067-7","article-title":"Time course of vertebral osteopenia in ovariectomized rats","volume":"10","author":"Wronski","year":"1989","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb2975","series-title":"Osteocytic osteolysis: Time for a second look? BoneKEy Reports","first-page":"229","volume":"1","author":"Wysolmerski","year":"2012"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb2980","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2013.01.025","article-title":"Osteocytes remove and replace perilacunar mineral during reproductive cycles","volume":"54","author":"Wysolmerski","year":"2013","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb2985","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/ijms23010377","article-title":"Animal model for glucocorticoid induced osteoporosis: A systematic review from 2011 to 2021","volume":"23","author":"Xavier","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108383_bb2990","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb2995","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138189","article-title":"Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone","volume":"10","author":"Xiong","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb3000","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/MJT.0000000000000446","article-title":"Alendronate for the treatment of osteoporosis in men: A meta-analysis of randomized controlled trials","volume":"24","author":"Xu","year":"2017","journal-title":"American Journal of Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108383_bb3005","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9201979","article-title":"Effects of 24 weeks of growth hormone treatment on bone microstructure and volumetric bone density in patients with childhood-onset adult GH deficiency","volume":"2020","author":"Yang","year":"2020","journal-title":"International Journal of Endocrinology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108383_bb3010","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb3015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00198-015-3308-6","article-title":"Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength","volume":"27","author":"Yao","year":"2016","journal-title":"Osteoporosis International"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108383_bb3020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11914-019-00500-6","article-title":"Hypoxia Signaling in the skeleton: Implications for bone health","volume":"17","author":"Yellowley","year":"2019","journal-title":"Current Osteoporosis Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb3025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta-analysis","volume":"10","author":"Yeung","year":"2019","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108383_bb3030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","article-title":"Glucocorticoids activate the local renin\u2013angiotensin system in bone: Possible mechanism for glucocorticoid-induced osteoporosis","volume":"47","author":"Yongtao","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2023.108383_bb3035","first-page":"89","article-title":"Ovariectomized rat model of osteoporosis: A practical guide","volume":"19","author":"Yousefzadeh","year":"2020","journal-title":"EXCLI Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108383_bb3040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/17425255.2015.1000860","article-title":"Denosumab for the treatment of osteoporosis","volume":"11","author":"Zaheer","year":"2015","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108383_bb3045","doi-asserted-by":"crossref","DOI":"10.5339\/gcsp.2015.66","article-title":"Andreas vesalius: Celebrating 500 years of dissecting nature","volume":"2015","author":"Zampieri","year":"2015","journal-title":"Global Cardiology Science and Practice"},{"issue":"9727","key":"10.1016\/j.pharmthera.2023.108383_bb3050","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","article-title":"Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: A cross-sectional study","volume":"375","author":"Zebaze","year":"2010","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108383_bb3055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(99)00228-8","article-title":"Bone mass changes during pregnancy and lactation in the rat","volume":"25","author":"Zeni","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2023.108383_bb3060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2016.02.005","article-title":"Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse","volume":"87","author":"Zhang","year":"2016","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb3065","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1128\/MCB.02120-05","article-title":"E11\/gp38 selective expression in osteocytes: Regulation by mechanical strain and role in dendrite elongation","volume":"26","author":"Zhang","year":"2006","journal-title":"Molecular and Cellular Biology"},{"issue":"46","key":"10.1016\/j.pharmthera.2023.108383_bb3070","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","article-title":"Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization","volume":"277","author":"Zhang","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"7693","key":"10.1016\/j.pharmthera.2023.108383_bb3075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature25743","article-title":"Structure and mechanogating mechanism of the Piezo1 channel","volume":"554","author":"Zhao","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb3080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00223-018-0439-8","article-title":"Sclerostin antibody reverses the severe sublesional bone loss in rats after chronic spinal cord injury","volume":"103","author":"Zhao","year":"2018","journal-title":"Calcified Tissue International"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108383_bb3085","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.M702687200","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108383_bb3090","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1161\/STROKEAHA.111.624650","article-title":"Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran","volume":"42","author":"Zhou","year":"2011","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108383_bb3095","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/adhm.201500070","article-title":"Bone as a structural material","volume":"4","author":"Zimmermann","year":"2015","journal-title":"Advanced Healthcare Materials"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:31:24Z","timestamp":1759012284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":618,"alternative-id":["S0163725823000475"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108383","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108383"}}